IDBS, a provider of enterprise scientific informatics platforms, has announced the appointment of Graeme Dennis as Pre-Clinical Pharma commercial director, Abhay Kini as director of product management and April Pisek as solutions consultant
Certara has announced that Craig Rayner, PharmD, MBA, senior vice president, integrated drug development with Certara Strategic Consulting, has been awarded the 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University.
The International Biomedical Research Alliance, a non-profit organisation which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Dr Ralph Korpman, is joining the Alliance’s board of directors
The Pistoia Alliance, has announced the results of a survey on the adoption of blockchain in the pharmaceutical and life science industries
Optibrium, Intellegens and Medicines Discovery Catapult have announced that they have been awarded a £1 million grant from Innovate UK to support the development of artificical Intelligence (AI) in drug discovery
Certara has announced that it has Pirana, a product for connecting and organising pharmacometric modelling results as well as providing interfaces to a range of software tools used in pharmacometrics modelling
Optibrium, a developer of software for drug discovery, has announced it has signed a collaboration agreement with Intellegens, a company developing novel artificial intelligence (AI) software
Citoxlab, a CRO for non-clinical research, has announced an investment and partnership deal with Experimental Pharmacology and Oncology Berlin-Buch (EPO), a CRO providing services for preclinical oncology research
Seattle-based Aptevo Therapeutics, a clinical-stage biotechnology company, is using Genedata Biologics software to accelerate cancer research
A partnership between the University of Essex and Provide aims to improve the Uk's National Health Service (NHS) by implementing an AI-powered decision-making engine to determine the service a patient needs
Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.
